HCID 11984299、化合物 → HCID 68955504、化合物
反応式
[CH2:1]([O:8][C:9]1[C:10]([C:27]([O:29]C)=O)=[N:11][NH:12][C:13]=1[C:14]([N:16]([CH2:18][CH:19](O)[C:20]1[CH:25]=[CH:24][CH:23]=[CH:22][N:21]=1)[CH3:17])=[O:15])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.Cl.[F:32][C:33]1[CH:40]=[CH:39][C:36]([CH2:37][NH2:38])=[C:35]([C:41]([NH:43][CH3:44])=[O:42])[CH:34]=1>>[CH2:1]([O:8][C:9]1[C:10]([C:27]([NH:38][CH2:37][C:36]2[CH:39]=[CH:40][C:33]([F:32])=[CH:34][C:35]=2[C:41]([NH:43][CH3:44])=[O:42])=[O:29])=[N:11][N:12]2[CH:19]([C:20]3[CH:25]=[CH:24][CH:23]=[CH:22][N:21]=3)[CH2:18][N:16]([CH3:17])[C:14](=[O:15])[C:13]=12)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1参加物
3
実験手順
The title compound was prepared from methyl 4-(benzyloxy)-5-{[(2-hydroxy-2-pyridin-2-ylethyl)(methyl)amino]carbonyl}-1H-pyrazole-3-carboxylate using a procedure similar to that described in Example 43, Steps 2-4, except that 4-fluoro-2-[(methylamino)carbonyl]benzylamine hydrochloride was used in place of 4-fluorobenzylamine. Purification was achieved by removing the solvent in vacuo, and purifying the resulting residue by reverse phase chromatography on a C-18 column using a gradient elution of 95-5% H2O (0.1% TFA)/CH3CN (0.1% TFA). Collection and concentration of the appropriate fractions afforded the product. ES MS (M+1)=543.
後処理
- customPurification
- customby removing the solvent in vacuo
- custompurifying the resulting residue by reverse phase chromatography on a C-18 column
- washa gradient elution of 95-5% H2O (0.1% TFA)/CH3CN (0.1% TFA)
- customCollection and concentration of the appropriate fractions
- customafforded the product
出典と根拠
- ORDレコード
- ord-7e4211e79039485f8e397b954cbbfc61
- 出典データセット
- uspto-grants-2009_01
- 特許番号
- US07476666B2
反応ノート
読み込み中…